TCG Crossover Management, LLC Diversified Active

Location: Palo Alto, CA

CIK: 0001839948 · Show all filings

Period: Q4 2024 (← Previous) (Next →)

Filing Date: Feb 14, 2025

Total Value: $1.023B (100.0% shares, 0.0% debt)

Holdings (38)

CGON CG ONCOLOGY INC 10.3%
Value $105M Shares 3,670,206 Est. Cost $40.67 Unrealized -15.9%
DYN DYNE THERAPEUTICS INC 6.1%
Value $62.44M Shares 2,650,150 Est. Cost $16.62 Unrealized +78.0%
XNCR XENCOR INC 5.5%
Value $56.35M Shares 2,452,138 Est. Cost $18.82 Unrealized +22.1%
COGT COGENT BIOSCIENCES INC 5.3%
Value $54.32M Shares 6,964,375 Est. Cost $9.05 Unrealized +10.1%
CNTA CENTESSA PHARMACEUTICALS PLC 4.7%
Value $48.42M Shares 2,890,816 Est. Cost $7.22 Unrealized
OCUL OCULAR THERAPEUTIX INC 4.4%
Value $45.43M Shares 5,319,148 Est. Cost $7.10 Unrealized +37.5%
UPB UPSTREAM BIO INC 4.4%
Value $44.86M Shares 2,801,763 Est. Cost $22.33 Unrealized 0.0%
ABVX ABIVAX SA AMERICAN DEPOSITARY SHARES 4.3%
Value $44.33M Shares 6,056,596 Est. Cost $12.76 Unrealized
SVRA SAVARA INC 3.7%
Value $37.95M Shares 12,362,205 Est. Cost $3.73 Unrealized -6.6%
TNGX TANGO THERAPEUTICS INC 3.2%
Value $33.17M Shares 10,736,000 Est. Cost $4.64 Unrealized 0.0%
DNTH DIANTHUS THERAPEUTICS INC 3.2%
Value $32.74M Shares 1,501,624 Est. Cost $25.71 Unrealized 0.0%
IRON DISC MEDICINE INC 3.0%
Value $30.87M Shares 486,957 Est. Cost $33.98 Unrealized +70.2%
MLYS MINERALYS THERAPEUTICS INC 3.0%
Value $30.41M Shares 2,470,265 Est. Cost $12.35 Unrealized +5.9%
TOURMALINE BIO INC 2.9%
Value $29.97M Shares 1,477,593 Est. Cost $25.14 Unrealized
GPCR STRUCTURE THERAPEUTICS INC 2.8%
Value $28.83M Shares 1,063,000 Est. Cost $43.45 Unrealized
TYRA TYRA BIOSCIENCES INC 2.7%
Value $27.65M Shares 1,989,103 Est. Cost $12.71 Unrealized +42.8%
EYPT EYEPOINT PHARMACEUTICALS INC 2.6%
Value $26.61M Shares 3,572,335 Est. Cost $10.51 Unrealized -11.4%
Cidara Therapeutics, Inc. 2.5%
Value $26.09M Shares 1,005,901 Est. Cost $25.94 Unrealized
THIRD HARMONIC BIO INC 2.5%
Value $25.78M Shares 2,505,424 Est. Cost $13.43 Unrealized
SLNO SOLENO THERAPEUTICS INC 2.4%
Value $24.72M Shares 550,000 Est. Cost $47.87 Unrealized +8.2%
ASTRIA THERAPEUTICS INC 2.4%
Value $24.69M Shares 2,761,861 Est. Cost $14.07 Unrealized
FULC FULCRUM THERAPEUTICS INC 2.4%
Value $24.68M Shares 5,250,000 Est. Cost $7.42 Unrealized -50.3%
SLN SILENCE THERAPEUTICS PLC 2.0%
Value $20.87M Shares 3,033,560 Est. Cost $14.21 Unrealized
RAPT Therapeutics, Inc. 1.9%
Value $19.75M Shares 13,135,260 Est. Cost $1.50 Unrealized
AMLX AMYLYX PHARMACEUTICALS INC 1.7%
Value $17.55M Shares 4,643,812 Est. Cost $2.25 Unrealized +109.3%
CMPS COMPASS PATHWAYS LTD 1.4%
Value $14.58M Shares 3,858,000 Est. Cost $7.40 Unrealized
KURA KURA ONCOLOGY INC 1.2%
Value $12.4M Shares 1,423,642 Est. Cost $14.54 Unrealized -1.1%
MBX MBX BIOSCIENCES INC 1.2%
Value $11.98M Shares 650,000 Est. Cost $22.87 Unrealized -6.8%
KOD KODIAK SCIENCES INC 1.1%
Value $11.4M Shares 1,145,538 Est. Cost $4.16 Unrealized +38.1%
TRDA ENTRADA THERAPEUTICS INC 1.0%
Value $10.11M Shares 584,955 Est. Cost $17.12 Unrealized
KROS KEROS THERAPEUTICS INC 0.9%
Value $8.707M Shares 550,000 Est. Cost $59.30 Unrealized -12.4%
ADVERUM BIOTECHNOLOGIES INC 0.8%
Value $8.39M Shares 1,796,482 Est. Cost $7.02 Unrealized
VTGN VISTAGEN THERAPEUTICS INC 0.8%
Value $7.896M Shares 2,676,580 Est. Cost $3.41 Unrealized -17.5%
AEROVATE THERAPEUTICS INC 0.6%
Value $5.938M Shares 2,240,809 Est. Cost $15.50 Unrealized
NEKTAR THERAPEUTICS 0.4%
Value $3.72M Shares 4,000,000 Est. Cost $0.93 Unrealized
AVTX AVALO THERAPEUTICS INC 0.4%
Value $3.589M Shares 483,000 Est. Cost $10.31 Unrealized +3.7%
VTYX VENTYX BIOSCIENCES INC 0.1%
Value $692K Shares 316,195 Est. Cost $29.94 Unrealized -92.4%
CABA CABALETTA BIO INC 0.0%
Value $197K Shares 86,795 Est. Cost $3.64 Unrealized -3.6%